Healthcare & Life Sciences
COUR Pharma
United Statescourpharma.com
COUR Pharma is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About COUR Pharma
COUR Pharma is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
COUR Pharma develops targeted antigen-specific therapies that reprogram the immune system to treat autoimmune diseases, with clinical trials underway for Type 1 Diabetes and Myasthenia Gravis.
Explore COUR Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.